DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Gane E, Schwabe C, Given B. , et al.
THU-176 - A phase 1 study to evaluate safety and tolerability of escalating single doses of the hepatitis B virus RNA interference drug ARC-521 in a healthy volunteer population.
J Hepatol 2017;
66: S265
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.